Yagi M, Kabata M, Ukai T, Ohta S, Tanaka A, Shimada Y, Sugimoto M, Araki K, Okita K, Woltjen K, Hochedlinger K, Yamamoto T, Yamada Y |
Yagi M, Kabata M, Ukai T, Ohta S, Tanaka A, Shimada Y, Sugimoto M, Araki K, Okita K, Woltjen K, Hochedlinger K, Yamamoto T, Yamada Y |
Yagi M, Kabata M, Ukai T, Ohta S, Tanaka A, Shimada Y, Sugimoto M, Araki K, Okita K, Woltjen K, Hochedlinger K, Yamamoto T, Yamada Y |
De Novo DNA Methylation at Imprinted Loci during Reprogramming into Naive and Primed Pluripotency.  |
De Novo DNA Methylation at Imprinted Loci during Reprogramming into Naive and Primed Pluripotency.  |
De Novo DNA Methylation at Imprinted Loci during Reprogramming into Naive and Primed Pluripotency.  |
Stem cell reports, 12, 5, 1113-1128 |
Stem cell reports, 12, 5, 1113-1128 |
Stem cell reports, 12, 5, 1113-1128 |
2019/05 |
有 |
|
|
公開 |
Morimoto H, Kanastu-Shinohara M, Ogonuki N, Kamimura S, Ogura A, Yabe-Nishimura C, Mori Y, Morimoto T, Watanabe S, Otsu K, Yamamoto T, Shinohara T |
Morimoto H, Kanastu-Shinohara M, Ogonuki N, Kamimura S, Ogura A, Yabe-Nishimura C, Mori Y, Morimoto T, Watanabe S, Otsu K, Yamamoto T, Shinohara T |
Morimoto H, Kanastu-Shinohara M, Ogonuki N, Kamimura S, Ogura A, Yabe-Nishimura C, Mori Y, Morimoto T, Watanabe S, Otsu K, Yamamoto T, Shinohara T |
ROS amplification drives mouse spermatogonial stem cell self-renewal. |
ROS amplification drives mouse spermatogonial stem cell self-renewal. |
ROS amplification drives mouse spermatogonial stem cell self-renewal. |
Life science alliance, 2, 2 |
Life science alliance, 2, 2 |
Life science alliance, 2, 2 |
2019/04 |
有 |
|
|
公開 |
Terada Y, Jo N, Arakawa Y, Sakakura M, Yamada Y, Ukai T, Kabata M, Mitsunaga K, Mineharu Y, Ohta S, Nakagawa M, Miyamoto S, Yamamoto T, Yamada Y |
Terada Y, Jo N, Arakawa Y, Sakakura M, Yamada Y, Ukai T, Kabata M, Mitsunaga K, Mineharu Y, Ohta S, Nakagawa M, Miyamoto S, Yamamoto T, Yamada Y |
Terada Y, Jo N, Arakawa Y, Sakakura M, Yamada Y, Ukai T, Kabata M, Mitsunaga K, Mineharu Y, Ohta S, Nakagawa M, Miyamoto S, Yamamoto T, Yamada Y |
Human Pluripotent Stem Cell-Derived Tumor Model Uncovers the Embryonic Stem Cell Signature as a Key Driver in Atypical Teratoid/Rhabdoid Tumor.  |
Human Pluripotent Stem Cell-Derived Tumor Model Uncovers the Embryonic Stem Cell Signature as a Key Driver in Atypical Teratoid/Rhabdoid Tumor.  |
Human Pluripotent Stem Cell-Derived Tumor Model Uncovers the Embryonic Stem Cell Signature as a Key Driver in Atypical Teratoid/Rhabdoid Tumor.  |
Cell reports, 26, 10, 2608-2621.e6 |
Cell reports, 26, 10, 2608-2621.e6 |
Cell reports, 26, 10, 2608-2621.e6 |
2019/03 |
有 |
|
|
公開 |
Matsui S, Ochiai M, Yasuda K, Mae SI, Kotaka M, Toyoda T, Yamamoto T, Osafune K |
Matsui S, Ochiai M, Yasuda K, Mae SI, Kotaka M, Toyoda T, Yamamoto T, Osafune K |
Matsui S, Ochiai M, Yasuda K, Mae SI, Kotaka M, Toyoda T, Yamamoto T, Osafune K |
Differentiation and isolation of iPSC-derived remodeling ductal plate-like cells by use of an AQP1-GFP reporter human iPSC line.  |
Differentiation and isolation of iPSC-derived remodeling ductal plate-like cells by use of an AQP1-GFP reporter human iPSC line.  |
Differentiation and isolation of iPSC-derived remodeling ductal plate-like cells by use of an AQP1-GFP reporter human iPSC line.  |
Stem cell research, 35, 101400 |
Stem cell research, 35, 101400 |
Stem cell research, 35, 101400 |
2019/03 |
有 |
|
|
公開 |
Hirata K, Kodama S, Nakano Y, Minaki-Nakagawa Y, Aoyama Y, Sakikubo M, Goto T, Yoshida M, Masui T, Yamamoto T, Uemoto S, Kawaguchi Y |
Hirata K, Kodama S, Nakano Y, Minaki-Nakagawa Y, Aoyama Y, Sakikubo M, Goto T, Yoshida M, Masui T, Yamamoto T, Uemoto S, Kawaguchi Y |
Hirata K, Kodama S, Nakano Y, Minaki-Nakagawa Y, Aoyama Y, Sakikubo M, Goto T, Yoshida M, Masui T, Yamamoto T, Uemoto S, Kawaguchi Y |
Exocrine tissue-driven TFF2 prevents apoptotic cell death of endocrine lineage during pancreas organogenesis.  |
Exocrine tissue-driven TFF2 prevents apoptotic cell death of endocrine lineage during pancreas organogenesis.  |
Exocrine tissue-driven TFF2 prevents apoptotic cell death of endocrine lineage during pancreas organogenesis.  |
Scientific reports, 9, 1, 1636 |
Scientific reports, 9, 1, 1636 |
Scientific reports, 9, 1, 1636 |
2019/02 |
有 |
|
|
公開 |
Kagawa H, Shimamoto R, Kim SI, Oceguera-Yanez F, Yamamoto T, Schroeder T, Woltjen K |
Kagawa H, Shimamoto R, Kim SI, Oceguera-Yanez F, Yamamoto T, Schroeder T, Woltjen K |
Kagawa H, Shimamoto R, Kim SI, Oceguera-Yanez F, Yamamoto T, Schroeder T, Woltjen K |
OVOL1 Influences the Determination and Expansion of iPSC Reprogramming Intermediates. |
OVOL1 Influences the Determination and Expansion of iPSC Reprogramming Intermediates. |
OVOL1 Influences the Determination and Expansion of iPSC Reprogramming Intermediates. |
Stem cell reports, 12, 2, 319-332 |
Stem cell reports, 12, 2, 319-332 |
Stem cell reports, 12, 2, 319-332 |
2019/02 |
有 |
|
|
公開 |
Yamashiro C, Sasaki K, Yabuta Y, Kojima Y, Nakamura T, Okamoto I, Yokobayashi S, Murase Y, Ishikura Y, Shirane K, Sasaki H, Yamamoto T, Saitou M |
Yamashiro C, Sasaki K, Yabuta Y, Kojima Y, Nakamura T, Okamoto I, Yokobayashi S, Murase Y, Ishikura Y, Shirane K, Sasaki H, Yamamoto T, Saitou M |
Yamashiro C, Sasaki K, Yabuta Y, Kojima Y, Nakamura T, Okamoto I, Yokobayashi S, Murase Y, Ishikura Y, Shirane K, Sasaki H, Yamamoto T, Saitou M |
Generation of human oogonia from induced pluripotent stem cells in vitro. |
Generation of human oogonia from induced pluripotent stem cells in vitro. |
Generation of human oogonia from induced pluripotent stem cells in vitro. |
Science (New York, N.Y.), 362, 6412, 356-360 |
Science (New York, N.Y.), 362, 6412, 356-360 |
Science (New York, N.Y.), 362, 6412, 356-360 |
2018/10 |
有 |
|
|
公開 |
Sogabe Y, Seno H, Yamamoto T, Yamada Y |
Sogabe Y, Seno H, Yamamoto T, Yamada Y |
Sogabe Y, Seno H, Yamamoto T, Yamada Y |
Unveiling epigenetic regulation in cancer, aging, and rejuvenation with in vivo reprogramming technology. |
Unveiling epigenetic regulation in cancer, aging, and rejuvenation with in vivo reprogramming technology. |
Unveiling epigenetic regulation in cancer, aging, and rejuvenation with in vivo reprogramming technology. |
Cancer science, 109, 9, 2641-2650 |
Cancer science, 109, 9, 2641-2650 |
Cancer science, 109, 9, 2641-2650 |
2018/09 |
有 |
|
|
公開 |
Ito Y, Nakamura S, Sugimoto N, Shigemori T, Kato Y, Ohno M, Sakuma S, Ito K, Kumon H, Hirose H, Okamoto H, Nogawa M, Iwasaki M, Kihara S, Fujio K, Matsumoto T, Higashi N, Hashimoto K, Sawaguchi A, Harimoto KI, Nakagawa M, Yamamoto T, Handa M, Watanabe N, Nishi E, Arai F, Nishimura S, Eto K |
Ito Y, Nakamura S, Sugimoto N, Shigemori T, Kato Y, Ohno M, Sakuma S, Ito K, Kumon H, Hirose H, Okamoto H, Nogawa M, Iwasaki M, Kihara S, Fujio K, Matsumoto T, Higashi N, Hashimoto K, Sawaguchi A, Harimoto KI, Nakagawa M, Yamamoto T, Handa M, Watanabe N, Nishi E, Arai F, Nishimura S, Eto K |
Ito Y, Nakamura S, Sugimoto N, Shigemori T, Kato Y, Ohno M, Sakuma S, Ito K, Kumon H, Hirose H, Okamoto H, Nogawa M, Iwasaki M, Kihara S, Fujio K, Matsumoto T, Higashi N, Hashimoto K, Sawaguchi A, Harimoto KI, Nakagawa M, Yamamoto T, Handa M, Watanabe N, Nishi E, Arai F, Nishimura S, Eto K |
Turbulence Activates Platelet Biogenesis to Enable Clinical Scale Ex Vivo Production. |
Turbulence Activates Platelet Biogenesis to Enable Clinical Scale Ex Vivo Production. |
Turbulence Activates Platelet Biogenesis to Enable Clinical Scale Ex Vivo Production. |
Cell, 174, 3, 636-648.e18 |
Cell, 174, 3, 636-648.e18 |
Cell, 174, 3, 636-648.e18 |
2018/07 |
有 |
|
|
公開 |
Shibata H, Komura S, Yamada Y, Sankoda N, Tanaka A, Ukai T, Kabata M, Sakurai S, Kuze B, Woltjen K, Haga H, Ito Y, Kawaguchi Y, Yamamoto T, Yamada Y |
Shibata H, Komura S, Yamada Y, Sankoda N, Tanaka A, Ukai T, Kabata M, Sakurai S, Kuze B, Woltjen K, Haga H, Ito Y, Kawaguchi Y, Yamamoto T, Yamada Y |
Shibata H, Komura S, Yamada Y, Sankoda N, Tanaka A, Ukai T, Kabata M, Sakurai S, Kuze B, Woltjen K, Haga H, Ito Y, Kawaguchi Y, Yamamoto T, Yamada Y |
In vivo reprogramming drives Kras-induced cancer development.  |
In vivo reprogramming drives Kras-induced cancer development.  |
In vivo reprogramming drives Kras-induced cancer development.  |
Nature communications, 9, 1, 2081 |
Nature communications, 9, 1, 2081 |
Nature communications, 9, 1, 2081 |
2018/05 |
有 |
|
|
公開 |
Ikeda T, Hikichi T, Miura H, Shibata H, Mitsunaga K, Yamada Y, Woltjen K, Miyamoto K, Hiratani I, Yamada Y, Hotta A, Yamamoto T, Okita K, Masui S |
Ikeda T, Hikichi T, Miura H, Shibata H, Mitsunaga K, Yamada Y, Woltjen K, Miyamoto K, Hiratani I, Yamada Y, Hotta A, Yamamoto T, Okita K, Masui S |
Ikeda T, Hikichi T, Miura H, Shibata H, Mitsunaga K, Yamada Y, Woltjen K, Miyamoto K, Hiratani I, Yamada Y, Hotta A, Yamamoto T, Okita K, Masui S |
Srf destabilizes cellular identity by suppressing cell-type-specific gene expression programs.  |
Srf destabilizes cellular identity by suppressing cell-type-specific gene expression programs.  |
Srf destabilizes cellular identity by suppressing cell-type-specific gene expression programs.  |
Nature communications, 9, 1, 1387 |
Nature communications, 9, 1, 1387 |
Nature communications, 9, 1, 1387 |
2018/04 |
有 |
|
|
公開 |
太田翔、山本拓也 |
太田翔、山本拓也 |
太田翔、山本拓也 |
体細胞初期化過程における選択的スプライシングの変化とその分子機構 |
体細胞初期化過程における選択的スプライシングの変化とその分子機構 |
体細胞初期化過程における選択的スプライシングの変化とその分子機構 |
生化学, 86, 6, 807-811 |
生化学, 86, 6, 807-811 |
生化学, 86, 6, 807-811 |
2014/12 |
有 |
日本語 |
|
公開 |